01. Constipation

Resident Editor: Kendra Moore, MD, MBE

Faculty Editor: Aparajita Singh, MD, MPH

BOTTOM LINE

✔ Constipation is extremely common but only rarely due to life threatening disease

✔ If feasible, discontinue meds that can cause constipation before considering testing  

✔ Add suppository or enema if impacted or severely constipated

Background

  • Constipation is extremely common: prevalence about 16% in adults overall and 33% adults >60
  • Cause of 2.5M physician visits and 92,000 hospital visits annually

Diagnostic criteria for functional constipation (Rome IV):

  • 2+ of the following for at least 3 months:
    • <3 spontaneous BMs per week
    • straining during >25% of BMs
    • lumpy or hard stools during >25% of BMs
    • sensation of incomplete evacuation during >25% of BMs
    • sensation of anorectal obstruction for >25% of BMs
    • Manuel maneuvers to facilitate >25% of BMs
  • Loose stools are rarely present without the use of laxatives
  • Insufficient criteria for IBS- consider this particularly if there is recurrent abd pain

DDx:

Types of functional constipation:

  • Normal transit (normal frequency but hard stool or straining) 
  • Slow transit (due to abnormal innervation or visceral myopathy)
  • Disorders of defecation: lack of coordination of recto-anal and pelvic muscles

Secondary causes:

  • Drugs:  including anticholinergics (antihistamines, antispasmodics, antidepressants, and antipsychotics), antacids, iron supplements, opiates, calcium channel blockers, calcium, diuretics, and anti-parkinsonian drugs
  • Obstruction: Cancer, strictures, adhesions, rectocele, external compression
  • Endocrine: hypothyroidism, diabetes, hyperparathyroidism, panhypopituitarism
  • Metabolic: hypercalcemia, hypokalemia hypomagnesemia, uremia
  • Neurologic: spinal cord injury, parkinsonism, MS, CVA, Hirschprung
  • Psychiatric: depression, anorexia nervosa, physical and sexual abuse
  • Miscellaneous: amyloid, scleroderma, immobility

Evaluation

  • History – Features of IBS (ie associated with abd pain), features of pelvic floor dysfunction (ie excessive straining, digital manipulation, spending long time evacuating)
    • Alarm features (colonoscopy recommended) – GI bleeding, change in stool caliber, weight loss >10 lb, family history of colon cancer, anemia, + FOBT, >50 with acute onset
  • Physical – Abdominal palpable mass, rectal exam to r/o mass/impaction, anal sphincter muscle function
  • Tests
    • In the absence of alarm signs and symptoms only a CBC is necessary. Unless other clinical features warrant otherwise, Chem Panel, TSH are not recommended just for chronic constipation.
    • A colonoscopy should not be performed routinely in all patients. Only those with alarm features or those who are due for colon cancer screening should undergo colonoscopy.
    • If history is suggestive of pelvic floor dysfunction – refer for ano-rectal manometry (simple test, done without sedation) to confirm the diagnosis.
    • These patients may respond well to fiber/laxative but treatment with biofeedback is quite successful (improvement in 70% patients) with training to relax the pelvic floor and restore recto-anal coordination.
    • Colonic Transit study done with sitz marker (multiple X rays after swallowing radiopaque markers) usually considered if patients fail  medical management and have refractory symptoms

Treatment for primary constipation:

Step 1: lifestyle modifications: increased water and fiber intake, increased exercise. Recommended water intake is 8 cups a day and fiber intake is 25-30g/day. 2/3 of Americans don't get their recommended daily amount of fiber.

In general, the average content of dietary fiber per serving of each of the food groups is:

Fruits and vegetables—1 to 3 grams
Nuts—2 to 3 grams per ounce
Beans, chickpeas, lentils; most berries—4 to 6 grams
White bread, white rice, refined pasta—less than 1 gram

Unrefined grains such as bran, whole wheat bread, brown rice and barley are excellent sources of fiber. Bulgar, barley, quinoa, oatmeal and bran cereals have between 3 and 6 grams per half cup.

Step 2: Add an inexpensive osmotic agent such as polyethylene glycol or milk of magnesia.

Step 3: Add stimulant laxative (eg bisacodyl oral or suppository or glycerine suppositories). Suppositories are preferably administered 30 min before meals to synergize with the gastrocolic response.

Laxative Agents:

Type

Names

Time of Onset

Side effects

Bulking

(MOA: increase stool bullk and GI motility, decrease colonic transit time)

Bran, psyllium (metamucil, konsyl) methylcellulose  (Citrucel),  wheat dextran (Benefiber), calcium polycarbophil (FiberCon)

12-72h

Bloating, flatulence most common w/ psyllium (increase dose gradually to avoid side effects)

Surfactant

(MOA:  Lower surface tension of stool. Found to be inferior to psyllium for effectiveness)

Docusate (Colace)

24-48h

Well tolerated but poor efficacy

Osmotic Agents

(MOA: draw fluid into small bowel lumen)

polyethylene glycol (Miralax)

Milk of magnesia (MOM), sorbitol, lactulose,

30m-6h for MOM, 24-48h for other agents

Bloating (lactulose worst offender, seen in 20%)

Mag toxicity with MOM (Avoid in renal failure)

Stimulants

(MOA: alter electrolyte transport and increase motor activity)

Bisacodyl (Dulcolax), senna, sodium picosulfate

6-12h

Abd cramps (56% in bisacodyl, 12% in senna)

Suppository

(MOA: local rectal stimulation, most helpful in pelvic floor dysfunction)

Bisacodyl, glycerin

30m-1h

Rectal irritation

Fluid enemas

(MOA: mechanical lavage)

Tap water enema, phosphate enema (Fleet’s)

 

Usually immediate

phosphate enema can cause electrolyte imbalance, avoid in elderly and with renal failure, heart failure 

Lubricant

(MOA: lubricates stool, not a preferred agent due to side effects)

Mineral oil

 

Lipid pneumonia, mal-absorption of fat-soluble vitamins

Peripheral mu agonist
(MOA: reverses effects of opiates on peripheral receptors)

Methylnaltrexone

30-60m

Diarrhea, abd pain

Other (only considered for refractory cases due to $$)

Lubiprostone (Cl channel activator in intestine; Linaclotide (Linzess, increases cGMP to decrease transit time); Plecanatide (Trulance, builds up levels of cGMP); Prucalopride (Resolor, 5HT-4 agonist)

Daily medication rather than PRN

Diarrhea (16% in Linzess)

When to refer:  Refractory symptoms, red flag symptoms or symptoms suggestive of pelvic floor dysfunction- refer to gastroenterology for colonoscopy, ano-rectal manometry or colonic transit study

References

American Gastroenterological Association Medical Position Statement: Guidelines on constipation. Gastroenterology 2013:144:211-217

Drossman DA, Hasker WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016; 150:1257–1261.

Jamshed et al. Diagnostic approach to chronic constipation in adults. Am Fam Physician. 2011 Aug 1;84(3):299-306.

Longstreth et al. Functional Bowel Disorders. Gastroenterology. 2006;130 (5):1480

Mounsey et al. Management of constipation in older adults. Am Fam Physician. 2015 Sep 15;92(6):500-504.